Abarelix (3000554414)
From Concept Hub
Concept Properties
| NCID Code | 3000554414 |
|---|---|
| Concept Status | Active (1024) |
| Superceded By | NA |
| Go to edit page: |
|---|
| Definitions |
| Representations |
| + Relationships |
| + Mappings |
Concept Definitions
This concept has the following definitions (descriptions of the meaning of the concept).
| Concept Definition | Language Code | Preferred? |
|---|---|---|
| An injectable gonadotropin-releasing hormone antagonist; used in oncology to reduce the amount of testosterone made in patients with advanced symptomatic prostate cancer. | en | No |
Representations
This concept has the following representations (also known as designations or surface forms).
| Representation | Languge Code | Preferred? |
|---|---|---|
| <protect>Abarelix</protect> | en | Yes |
| C72H95ClN14O14 | en | No |
| N-Acetyl-3-(2-naphthyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridyl)-D-alanyl-L-seryl-N-methyl-L-tyrosyl-D-asparaginyl-L-leucyl-N6-isopropyl-L-lysyl-L-prolyl-D-alaninamide | en | No |
